5 results
DRS/A
MLYS
Mineralys Therapeutics Inc
29 Dec 22
Draft registration statement (amended)
12:00am
approvals of such product, or seek an injunction against its manufacture or distribution;
we may be required to recall a product or change the way … by regulatory authorities;
requirements to cease development or to recall batches of lorundrostat or any future product candidates; and
in the event
DRS/A
MLYS
Mineralys Therapeutics Inc
7 Dec 22
Draft registration statement (amended)
12:00am
may be required to recall a product or change the way such product is administered to patients;
regulatory authorities may require additional … to additional inspections by regulatory authorities;
requirements to cease development or to recall batches of MLS-101 or any future product candidates
DRS
MLYS
Mineralys Therapeutics Inc
4 Nov 22
Draft registration statement
12:00am
approvals of such product, or seek an injunction against its manufacture or distribution;
we may be required to recall a product or change the way … potential future manufacturing facilities to additional inspections by regulatory authorities;
requirements to cease development or to recall batches
DRS
EX-10.9
MLYS
Mineralys Therapeutics Inc
4 Nov 22
Draft registration statement
12:00am
all sales of Products in each country of the MINERALYS Territory.
6.7 Product Recalls. If MINERALYS believes that a recall of any Product sold … in the MINERALYS Territory is necessary, MINERALYS shall promptly undertake or have undertaken such recall and provide [***] notice to MTPC. Any decision
- Prev
- 1
- Next